comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 11:46:22 - browse：171

A photograph of someone preparing small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at an in vitro fertilization lab — In vitro fertilization lab staff prepare small petri dishes, each holding embryos. (This sample image doesn't necessarily show embryos grown in media from CooperSurgical, a supply giant now facing lawsuits.) Michael Wyke/AP

Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging that fluid the company sent to in vitro fertilization clinics destroyed their embryos.

The fluid, called culture media, is filled with nutrients that allow embryos to develop enough to ultimately be implanted into a uterus. CooperSurgical acknowledged that the batch of fluid may have stunted embryo growth in a product recall notice, but it hasn’t disclosed exactly what went wrong. Lawsuits claim the media lacked magnesium, a key nutrient, while a Cooper representative told STAT the cause is still under investigation.

The recall could be a one-off manufacturing fluke. But the debacle, and the uncertainty around the problems with the fluid, sheds light on a larger problem: IVF doctors rarely know the exact composition of culture media in the first place. The Food and Drug Administration asks manufacturers for a list of materials before the media goes on the market, an FDA spokesperson told STAT. Companies will sometimes give clinics this information voluntarily, along with required labeling information like mouse embryo data, instructions for use, and warnings. But the FDA doesn’t require companies to list the ingredients or their proportions publicly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

WSS

Welsh Carson private equity firm escapes from FTC antitrust case

FogPharma raises $145 million in rare Series E round

Brain technologies pose threats that are all too real, experts warn

AI for drug discovery: Experts on separating hype from reality

Change Healthcare cyberattack outage could last weeks

Deliver public health messages at the right time

hotspot

comprehensive

explore

Novavax promises a turnaround & Lilly roils the obesity market

How to address the problem of discarded donor organs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Brain MRIs reveal impact of 'toxic stress' on Black children

After affirmative action ruling, medical educators look to 'holistic review'

Medical device lobby: We're tired of waiting on Medicare coverage

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Sports medicine is finally prioritizing gender equality

Deliver public health messages at the right time

hotspot

Chemotherapy before breast cancer surgery might fuel metastasis

RaDonda Vaught to speak at CommonSpirit event on patient safety

BIO to announce reorganization, senior leaders expected to depart

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Kenai launches with $82 million for Parkinson’s stem cell therapy

House looks to weaken Medicare negotiation

leisure time

hotspot

focus

leisure time